IDOL regulates systemic energy balance through control of neuronal VLDLR expression
Open accessAbstract
Liver X receptors limit cellular lipid uptake by stimulating the transcription of Inducible Degrader of the LDL Receptor (IDOL), an E3 ubiquitin ligase that targets lipoprotein receptors for degradation. The function of IDOL in systemic metabolism is incompletely understood. Here we show that loss of IDOL in mice protects against the development of diet-induced obesity and metabolic dysfunction by altering food intake and thermogenesis. Unexpectedly, analysis of tissue-specific knockout mice revealed that IDOL affects energy balance, not through its actions in peripheral metabolic tissues (liver, adipose, endothelium, intestine, skeletal muscle), but by controlling lipoprotein receptor abundance in neurons. Single-cell RNA sequencing of the hypothalamus demonstrated that IDOL deletion altered gene expression linked to control of metabolism. Finally, we identify VLDLR rather than LDLR as the primary mediator of IDOL effects on energy balance. These studies identify a role for the neuronal IDOL-VLDLR pathway in metabolic homeostasis and diet-induced obesity.
AI snapshot
Written from the paper’s full text.
TL;DR
IDOL deficiency protects mice from diet-induced obesity and metabolic dysfunction by acting in neurons rather than peripheral metabolic tissues. The phenotype requires neuronal VLDLR, not LDLR, and is linked to altered hypothalamic gene expression, food intake, and thermogenesis.
Key findings
- Global IDOL-knockout mice fed western diet for 15 weeks were 22% lighter than WT controls and averaged 11% body fat versus 32% in WT; they also showed improved glucose clearance and insulin tolerance.
- Liver-, adipose-, endothelial-, intestine-, and muscle-specific IDOL deletions did not recapitulate the global knockout phenotype, indicating peripheral metabolic tissues are not the primary drivers.
- IDOL–VLDLR double knockout mice were indistinguishable from VLDLR single knockouts and lost the protection seen with IDOL knockout, whereas IDOL–LDLR double knockout mice remained protected like IDOL knockouts, identifying VLDLR as the key mediator.
- CNS IDOL knockdown via intracerebroventricular ASO suppressed hypothalamic *Idol* expression by 65%, increased VLDLR protein, reduced weight after six weeks on diet (p<0.01), and increased energy expenditure; pan-neuronal IDOL knockout reduced food intake and adiposity.
Methods
- Mouse models included global IDOL knockouts from two independent lines, tissue-specific conditional knockouts (liver, adipose, endothelium, intestine, skeletal muscle, neurons), an adipose-specific dominant-active IDOL transgenic line, and IDOL–LDLR or IDOL–VLDLR double knockouts.
- Mice were challenged with chow, low-fat, high-fat, western, or high-fat/high-cholesterol diets; body mass, adiposity by MRI/DEXA, glucose and insulin tolerance, food intake, thermoneutrality, indirect calorimetry, histology, and western blotting were assessed.
- Hypothalamic single-cell RNA sequencing used Drop-seq; clustering identified 26 cell populations, including 15 neuronal populations, from 11,453 single cells, with differential expression tested by Wilcoxon rank sum test.
Limitations
- The paper states that specific hypothalamic regions responsible for the IDOL effect were not identified; viral-Cre deletion in ARC, VMH, or PVH did not recapitulate the neuronal knockout phenotype, and the authors note the viral-Cre approach may affect multiple neuronal populations.
- The paper states that acute CNS ASO knockdown did not show changes in food intake during a two-week evaluation, possibly due to acute versus chronic deletion or study duration.
- Evident from the text: most subsequent studies used male mice because females were resistant to diet-induced obesity, and the mechanistic ligand linking neuronal VLDLR to peripheral energy balance remains unresolved.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
18 of 33 cited sources checked · 12 supported · 0 flagged · accuracy not yet measured
- Premisecitation
IDOL controls the abundance of LDLR, VLDLR, and ApoER2 via ubiquitination, which targets the proteins for lysosomal degradation.
“IDOL controls the abundance of three proteins (LDLR, VLDLR, and ApoER2) via ubiquitination, which targets the proteins for lysosomal degradation9,13.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [9] Hong, C. et al. The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. J. Biol. Chem. 285, 19720–19726 (2010). source
- cites [13] Calkin, A. C. et al. FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors. Proc. Natl Acad. Sci. USA 108, 20107–20112 (2011). source
- Premisecitation
VLDLR-KO mice exhibited a reduction in mass and BMI relative to WT controls on a mixed background.
“One of the initial observations made by Herz and colleagues when they developed the VLDLR-KO mice was that the mice exhibited a reduction in mass and BMI relative to WT controls on a mixed background27.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [27] Frykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L. & Herz, J. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 92, 8453–8457 (1995). source
The Abstract reports that the authors produced VLDLR-knockout mice and detected a modest decrease in body weight and body mass index. Our copy does not specify a mixed genetic background or explicitly identify wild-type controls for that comparison. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Study design and conductcitation
The viral-Cre approach used here suffers from the inherent weakness that the SynI promoter-driven Cre will be expressed in all infected neurons, which might affect the role of specific neuronal populations.
“We acknowledge that the viral-Cre approach used here suffers from the inherent weakness that the SynI promoter-driven Cre will be expressed in all infected neurons, which might might the role of specific neuronal populations51.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [51] Mancini, G. & Horvath, T. L. Viral vectors for studying brain mechanisms that control energy homeostasis. Cell Metab. 27, 1168–1175 (2018). source
The supplied passage has no section or page label and contains only reference links, not discussion of the viral-Cre approach. Searches for SynI, promoter-driven Cre expression, and neuronal specificity found no substantive passage in our copy that addresses the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Whole-body deletion of VLDLR is protective against diet-induced obesity.
“Whole body deletion of VLDLR has previously been shown to be protective against diet-induced obesity22,27,28.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [22] Goudriaan, J. R. et al. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45, 1475–1481 (2004). source
- cites [27] Frykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L. & Herz, J. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 92, 8453–8457 (1995). source
The Abstract reports that mice lacking VLDL receptors had modestly lower body weight, body mass index, and adipose tissue mass. It mentions high-fat feeding but does not report that deletion specifically protected against diet-induced obesity, so the diet-specific claim goes beyond the passage. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [28] Goudriaan, J. R. et al. Protection from obesity in mice lacking the VLDL receptor. Arterioscler. Thromb. Vasc. Biol. 21, 1488–1493 (2001). source
- Findingown data
18-month-old chow-fed IDOL-KO mice are protected against age-induced obesity even on standard chow diet.
“18-month old chow-fed IDOL-KO mice (developed at UCLA) demonstrated that deletion of IDOL protected against age-induced obesity, even when the mice were fed standard chow diet”
Quote in the paperSubstantial claim
- Findingown data
Hepatic deletion of IDOL had no effect on glucose metabolism.
“nor on glucose metabolism (Extended Data Fig 2A, 2B), suggesting that the liver is not the primary driver of the global IDOL-KO phenotype.”
Quote in the paperSubstantial claim - Findingown data
Loss of IDOL in mice protects against the development of diet-induced obesity and metabolic dysfunction.
“Here we show that loss of IDOL in mice protects against the development of diet-induced obesity and metabolic dysfunction by altering food intake and thermogenesis.”
Quote in the paperSubstantial claim - Findingown data
Intestine-specific IDOL knockout did not affect glucose or insulin tolerance.
“and did not affect glucose or insulin tolerance (Extended Data Fig. 2G, 2H).”
Quote in the paperSubstantial claim - Findingown data
Viral-Cre-mediated deletion of IDOL in neurons in the arcuate nucleus, ventromedial hypothalamus, or paraventricular nucleus of the hypothalamus was not sufficient to recapitulate the CreSynI Idolf/f mouse phenotype.
“viral-Cre-mediated deletion of IDOL in neurons in the arcuate nucleus (ARC), ventromedial hypothalamus (VMH), or the paraventricular nucleus of the hypothalamus (PVH) was not sufficient to recapitulate the CreSynIIdolf/f mouse phenotype”
Quote in the paperSubstantial claim - Findingown data
Adipose-specific deletion of IDOL had no effect on glucose or insulin tolerance.
“or on glucose or insulin tolerance (Extended Data Fig. 2C, 2D).”
Quote in the paperSubstantial claim - Findingown data
The ASO findings were confirmed in a second cohort of mice using a CNS-optimized negative control ASO.
“These findings were confirmed in a second cohort of mice using a CNS-optimized negative control ASO”
Quote in the paperNot a substantial claim - Findingown data
No statistically significant differences in energy expenditure were detected between CreSynI Idolf/f and Idolf/f littermates by indirect calorimetry.
“We assessed energy expenditure by indirect calorimetry but did not detect any statistically significant differences between the two groups.”
Quote in the paperSubstantial claim - Findingown data
Adipose-specific transgenic IDOL mice are not protected from diet-induced obesity.
“Adipose-specific transgenic IDOL mice are not protected from diet-induced obesity.”
Quote in the paperSubstantial claim - Findingown data
Single-cell RNA sequencing of the hypothalamus demonstrated that IDOL deletion altered gene expression linked to control of metabolism.
“Single-cell RNA sequencing of the hypothalamus demonstrated that IDOL deletion altered gene expression linked to control of metabolism.”
Quote in the paperSubstantial claim - Findingown data
Vldlr is only appreciably expressed in neuron and oligodendrocyte cell populations in the hypothalamus.
“Vldlr is only appreciably expressed in neuron and oligodendrocyte cell populations.”
Quote in the paperSubstantial claim - Findingown data
Reduced food intake in IDOL-KO mice was associated with reduced diet-induced adipose expansion.
“associated with reduced diet-induced adipose expansion (Fig 1G, 1H).”
Quote in the paperSubstantial claim - Findingown data
Reduced adiposity in WD-fed IDOL-KO mice was associated with improved glucose clearance and insulin tolerance.
“The reduced adiposity in the WD-fed IDOL-KO mice was associated with improved glucose clearance (Fig. 1D; nine weeks of diet) and insulin tolerance (Fig. 1E; fourteen weeks of diet).”
Quote in the paperSubstantial claim - Findingown data
Acute knockdown of Idol in the central nervous system increases energy expenditure.
“Acute knockdown of Idol in the central nervous system increases energy expenditure.”
Quote in the paperSubstantial claim - Findingown data
IDOL-KO mice on western diet were leaner, averaging 11% body fat compared to 32% in WT mice.
“Body composition analysis by MRI revealed that IDOL-KO mice were leaner, averaging 11% body fat compared to 32% in the WT mice”
Quote in the paperSubstantial claim - Findingown data
Male IDOL knockout mice have unchanged lean body mass across test diets despite adiposity changes measured by MRI.
“Unchanged lean body mass in male IDOL knockout mice administered test diets despite adiposity changes measured by MRI.”
Quote in the paperNot a substantial claim - Findingown data
Clustering analysis revealed several populations of neurons with incompletely overlapping clusters of wild-type and IDOL knockout cells, indicating altered global transcriptional profiles in these populations.
“the clustering analysis revealed several populations of neurons that had incompletely overlapping clusters of wild-type and IDOL knockout cells (Fig. 5C). Such separations indicate altered global transcriptional profiles in these populations.”
Quote in the paperSubstantial claim - Findingown data
Global IDOL-KO mice housed at thermoneutrality gained less mass and adiposity on the obesogenic HFHC diet relative to WT mice.
“Relative to WT mice, global IDOL-KO mice gained less mass and adiposity on the obesogenic HFHC diet”
Quote in the paperSubstantial claim - Findingown data
Muscle-specific IDOL knockout failed to recapitulate the effects of whole-body IDOL loss.
“Again, the tissue-selective knockout failed to recapitulate the effects of whole-body IDOL loss (Fig. 2E, 2J and Extended Data Fig. 2I, 2J).”
Quote in the paperSubstantial claim - Findingown data
The increased energy expenditure in ASO-treated mice could not be explained by changes in locomotor activity.
“The increased energy expenditure could not be explained by changes in locomotor activity (Fig. 4G, 4H).”
Quote in the paperSubstantial claim - Findingown data
Endothelial-specific IDOL knockout had no difference in glucose or insulin tolerance.
“There was also no difference in glucose or insulin tolerance between groups (Extended Data Fig. 2E, 2F).”
Quote in the paperSubstantial claim - Findingown data
Loss of IDOL altered the expression of a battery of genes linked to energy balance in AGRP neurons.
“Analysis of transcript abundance in the AGRP neurons revealed that loss of IDOL altered the expression of a battery of genes linked to energy balance.”
Quote in the paperSubstantial claim - Findingown data
LDLR is not required for IDOL's effects on the response to high-fat diet.
“Furthermore, the only lipoprotein receptor target of IDOL that is expressed by the liver is the LDL receptor, which we unequivocally demonstrated was not required for IDOL’s effects on the response to high-fat diet (Fig. 3A, 3B).”
Quote in the paperSubstantial claim - Findingown data
CreR26/IDOL(AZ) mice maintained on low-fat low-cholesterol diet showed a lean phenotype after 20 weeks of age.
“When maintained on low-fat low-cholesterol diet (LFD), these CreR26/IDOL(AZ) mice also showed a lean phenotype after 20-weeks of age”
Quote in the paperSubstantial claim - Findingown data
Group-housed IDOL-deficient knockout mice fed a western diet for 15 weeks were 22% lighter than WT controls.
“Group-housed IDOL-deficient knockout mice fed a western diet (WD) enriched in fat and cholesterol for 15 weeks were 22% lighter than WT controls”
Quote in the paperSubstantial claim - Findingown data
IDOL-KO mice were also leaner when fed a high-fat diet that contained comparatively little cholesterol.
“however, the IDOL-KO mice were also leaner when fed a high-fat diet (HFD) that contained comparatively little cholesterol”
Quote in the paperSubstantial claim - Findingown data
Two key orexigenic genes, Agrp and Npy, were downregulated in the AGRP neurons of IDOL-KO mice.
“two key orexigenic genes expressed were downregulated in the AGRP neurons of IDOL-KO mice: the genes encoding agouti-related peptide and neuropeptide Y”
Quote in the paperSubstantial claim - Findingnone given
Loss of VLDLR but not LDLR expression on an IDOL-KO background abolished the protective effects of IDOL deficiency on the development of obesity.
“Loss of VLDLR but not LDLR expression on an IDOL-KO background abolished the protective effects of IDOL deficiency on the development of obesity.”
Quote in the paperSubstantial claim - Findingown data
IDOL KO and IDOL-LDLR DKO groups were indistinguishable with respect to body mass and adiposity on HFHC diet.
“Throughout the study, the IDOL KO and IDOL-LDLR DKO groups were indistinguishable with respect to body mass and adiposity (Fig. 3A, 3E).”
Quote in the paperSubstantial claim - Findingown data
Intestine-specific IDOL knockout did not affect mass gain or adiposity.
“loss of IDOL activity in the intestine did not affect mass gain or adiposity (Fig. 2D, 2I)”
Quote in the paperSubstantial claim - Findingown data
VLDLR single knockout mice and IDOL-VLDLR DKO mice showed comparable protection against adipose expansion upon high-fat diet feeding.
“The VLDLR single knockout mice and IDOL-VLDLR DKO showed comparable protection against adipose expansion upon high-fat diet feeding”
Quote in the paperSubstantial claim - Findingown data
40 μg given by intracerebroventricular injection was the minimum dose required for maximal suppression of Idol expression in whole brain homogenates collected two weeks after injection.
“Dose-response studies determined that 40 μg given by intracerebroventricular injection was the minimum dose required for maximal suppression of Idol expression in whole brain homogenates collected two weeks after the injection”
Quote in the paperSubstantial claim - Findingown data
Mice treated with the IDOL ASO weighed less than their control counterparts after six weeks on diet.
“The mice treated with the IDOL ASO weighed less than their control counterparts after six weeks on diet”
Quote in the paperSubstantial claim - Findingown data
ASO-treated mice show reduced lipid accumulation in the liver by hematoxylin and eosin staining.
“Reduced lipid accumulation in the livers of ASO treated mice evident with hematoxylin and eosin staining of 5μm sections of liver (10x objective).”
Quote in the paperNot a substantial claim - Findingown data
Deletion of IDOL from neurons in the arcuate nucleus had no effect on body mass or food intake in mice fed a western diet for 12 weeks.
“Deletion of IDOL from neurons in the ARC had no effect on body mass or food intake for mice fed a western diet for 12 weeks”
Quote in the paperSubstantial claim- Rests on an assumption: Infection of neurons with AAV-hSyn-GFP-Cre in the arcuate nucleus or paraventricular nucleus of the hypothalamus successfully deletes IDOL in those neurons.
- Findingown data
Long-term singly housed analysis revealed reduced food intake in the genetic absence of IDOL.
“analysis of mice housed singly over the course of weeks (WT, n=14; IDOL KO, n=12) revealed reduced food intake in the genetic absence of IDOL”
Quote in the paperSubstantial claim - Findingown data
Neuron-specific virogenetic deletion of IDOL from individual hypothalamic nuclei is insufficient to protect against diet-induced obesity.
“Neuron-specific virogenetic deletion of IDOL from individual hypothalamic nuclei is insufficient to protect against diet-induced obesity.”
Quote in the paperSubstantial claim- Rests on an assumption: Infection of neurons with AAV-hSyn-GFP-Cre in the arcuate nucleus or paraventricular nucleus of the hypothalamus successfully deletes IDOL in those neurons.
- Findingown data
Single cell RNA-seq demonstrated that deletion of IDOL altered the transcriptional landscape in several populations of neurons with well-established roles in the regulation of energy balance.
“Furthermore, our single cell RNA-seq study demonstrated that deletion of IDOL altered the transcriptional landscape in several populations of neurons with well-established roles in the regulation of energy balance.”
Quote in the paperSubstantial claim - Findingown data
Idol knockdown in the CNS was associated with increased VLDLR protein in the hypothalamus.
“As expected, Idol knockdown in the CNS was associated with increased VLDLR protein in the hypothalamus”
Quote in the paperSubstantial claim - Findingown data
Hepatic deletion of IDOL had no effect on obesity of mice challenged with the obesogenic HFHC diet.
“Hepatic deletion of IDOL had no effect on the obesity of mice challenged with the obesogenic HFHC diet (Fig. 2A, 2F)”
Quote in the paperSubstantial claim - Findingown data
CreSynI Idolf/f mice had reduced mass and adiposity when challenged with the western diet.
“Similar to the global-KO mice, the CreSynIIdolf/f mice had reduced mass and adiposity when challenged with the western diet (Fig. 6A, 6B; n=18).”
Quote in the paperSubstantial claim - Findingown data
Loss of liver IDOL did not confer protection against diet-induced metabolic dysfunction.
“We tested the role of IDOL in the liver directly with hepatocyte-specific conditional IDOL-KO mice (Albumin-Cre; Fig. 2) and found that loss of liver IDOL did not confer protection against diet-induced metabolic dysfunction.”
Quote in the paperSubstantial claim - Findingown data
Western blot analysis of subcutaneous white adipose tissue showed enhanced phosphorylation of HSL in CreSynI Idolf/f mice.
“Western blot analysis of subcutaneous white adipose tissue showed enhanced phosphorylation of HSL in CreSynIIdolf/f mice (Fig. 6D).”
Quote in the paperSubstantial claim - Findingown data
ASO-treated mice exhibited increased energy expenditure.
“The ASO-treated mice exhibited increased energy expenditure (Fig. 4F)”
Quote in the paperSubstantial claim - Findingown data
The lean phenotype of CreR26/IDOL(AZ) mice was exaggerated when challenged with a high-fat high-cholesterol diet.
“The phenotype was exaggerated when the mice were challenged with a high-fat high-cholesterol diet (HFHC; Extended Data Fig. 1E).”
Quote in the paperNot a substantial claim - Findingown data
ASO treatment increased phosphorylation of hormone sensitive lipase in the subcutaneous white adipose depot.
“ASO treatment increased phosphorylation of hormone sensitive lipase in the subcutaneous white adipose depot (Fig. 4I)”
Quote in the paperNot a substantial claim - Findingown data
Vldlr gene expression had two clusters with significant numbers of cells with high Vldlr expression: oligodendrocytes and neurons.
“We analyzed the dataset for Vldlr gene expression and found two clusters with significant numbers of cells with high Vldlr expression: oligodendrocytes and neurons”
Quote in the paperSubstantial claim - Findingnone given
The consequence of IDOL deficiency is increased, rather than decreased, VLDLR protein levels.
“It is important to point out, however, that the consequence of IDOL deficiency is increased, rather than decreased, VLDLR protein levels.”
Quote in the paperSubstantial claim - Findingown data
Adipose-specific deletion of IDOL in white and brown fat had no effect on mass or adiposity after 15 weeks of western-diet feeding.
“We challenged the mice with 15 weeks of western-diet feeding but saw no effect on mass or adiposity (Fig. 2B, 2G)”
Quote in the paperSubstantial claim - Findingown data
At the end of the seven-week western diet study, Idol expression was suppressed by 65% in the hypothalamus of ASO-injected mice relative to vehicle-treated control mice.
“At the end of the seven-week western diet study, Idol expression was suppressed by 65% in the hypothalamus of ASO-injected mice relative to vehicle-treated control mice”
Quote in the paperSubstantial claim - Findingown data
CreSynI Idolf/f mice consumed less food per week than their Idolf/f littermates.
“As shown in Fig. 6C, the CreSynIIdolf/f mice consumed less food per week than their Idolf/f littermates.”
Quote in the paperSubstantial claim - Findingown data
No changes to food intake were observed in IDOL ASO-treated mice.
“Although IDOL ASO-treated mice phenocopied the whole-body IDOL KO mice, we did not observe changes to food intake.”
Quote in the paperSubstantial claim - Findingown data
More modest differences were observed between genotypes in POMC and histaminergic neurons.
“More modest differences were observed between genotypes in POMC and histaminergic neurons”
Quote in the paperNot a substantial claim - Findingown data
Livers of the IDOL ASO-treated mice had less lipid deposition.
“Livers of the IDOL ASO-treated mice had less lipid deposition, similar to the global IDOL KO mice”
Quote in the paperNot a substantial claim - Findingown data
Differentially expressed genes identified in AGRP neurons showed enrichment of genes annotated in GWAS, OMIM or PubMed as associated with energy homeostasis.
“The differentially expressed genes identified in AGRP neurons showed an enrichment of these genes (Fig. 5D).”
Quote in the paperNot a substantial claim - Findingown data
Drop-seq identified twenty-six populations of cells in the hypothalamus, including eleven non-neuronal populations and fifteen distinct populations of neurons.
“Clustering algorithms successfully identified twenty-six populations of cells in the hypothalamus, including eleven non-neuronal populations and fifteen distinct populations of neurons”
Quote in the paperNot a substantial claim - Findingown data
18-month-old IDOL knockout mice are protected against age-induced adiposity.
“18-month-old IDOL KO mice are protected against age-induced adiposity.”
Quote in the paperSubstantial claim - Findingown data
Deletion of IDOL leads to an over-abundance of VLDLR protein.
“deletion of IDOL, which leads to an over-abundance of VLDLR protein (Extended Data Fig. 4A, 4B)”
Quote in the paperSubstantial claim - Findingown data
ASO treatment increased abundance of tyrosine hydroxylase in the BAT.
“and we noted increased abundance of tyrosine hydroxylase in the BAT (Fig. 4J), consistent with increased catecholamine production by sympathetic nerves.”
Quote in the paperSubstantial claim - Findingown data
Deletion of IDOL from neurons in the paraventricular nucleus of the hypothalamus had no effect on body mass or food intake in mice fed a western diet for 12 weeks.
“Deletion of IDOL from neurons in the PVH had no effect on body mass or food intake for mice fed a western diet for 12 weeks”
Quote in the paperSubstantial claim- Rests on an assumption: Infection of neurons with AAV-hSyn-GFP-Cre in the arcuate nucleus or paraventricular nucleus of the hypothalamus successfully deletes IDOL in those neurons.
- Findingown data
The treatment effect on energy expenditure was significant (p<0.05 by ANCOVA) when either overall mean total body mass or mean lean body mass was used as the covariate.
“The treatment effect was significant (p<0.05 by ANCOVA) when either the overall mean total body mass or the mean lean body mass of each treatment group was used as the covariate.”
Quote in the paperSubstantial claim - Findingown data
Endothelial-specific IDOL knockout had no effect on the initiation or progression of obesity after WD for 15 weeks.
“Loss of IDOL activity in the endothelium had no effect on the initiation or progression of obesity after challenge with WD for 15 weeks (Fig. 2C, 2H).”
Quote in the paperSubstantial claim - Findingown data
aP2-IDOL transgenic mice showed nearly complete ablation of VLDLR protein levels in both white and brown adipose depots.
“This line showed nearly complete ablation of VLDLR protein levels in both white and brown adipose depots, confirming the activation of the IDOL pathway”
Quote in the paperSubstantial claim - Study design and conductown data
There are no statistically significant differences in body composition at the onset of the CLAMS experiment between ASO-treated and control mice.
“No statistically significant differences in body composition at the onset of CLAMS experiment.”
Quote in the paperSubstantial claim - Interpretationown data
Our data do not support a causal role for hepatic IDOL in the phenotype.
“By contrast, our data do not support a causal role for hepatic IDOL in the phenotype.”
Quote in the paperSubstantial claim - Interpretationown data
IDOL affects energy balance not through its actions in peripheral metabolic tissues but by controlling lipoprotein receptor abundance in neurons.
“Unexpectedly, analysis of tissue-specific knockout mice revealed that IDOL affects energy balance, not through its actions in peripheral metabolic tissues (liver, adipose, endothelium, intestine, skeletal muscle), but by controlling lipoprotein receptor abundance in neurons.”
Quote in the paperSubstantial claim - Interpretationown data
Deletion of IDOL in the CNS altered the transcriptional regulation of several key neural circuits known to regulate energy balance.
“Collectively, these data reveal that deletion of IDOL in the CNS altered the transcriptional regulation of several key neural circuits known to regulate energy balance.”
Quote in the paperSubstantial claim - Interpretationown data
IDOL-mediated regulation of neuronal VLDL receptor is a previously unrecognized modulator of whole-body energy homeostasis.
“They further identify IDOL-mediated regulation of neuronal VLDL receptor as a previously unrecognized modulator of whole-body energy homeostasis.”
Quote in the paperSubstantial claim - Interpretationown data
The relative importance of altered food intake to the phenotype was confirmed by thermoneutrality studies showing that body weight differences persisted when the role of thermogenesis was minimized.
“The relative importance of altered food intake to the phenotype was confirmed by thermoneutrality studies showing that body weight differences persisted when the role of thermogenesis was minimized.”
Quote in the paperSubstantial claim - Interpretationown data
The changes in food intake in IDOL-deficient mice are the result of primary IDOL effects in neurons.
“This finding shows that the changes in food intake in IDOL-deficient mice are the result of primary IDOL effects in neurons.”
Quote in the paperSubstantial claim - Interpretationreasoning
The observed changes in abundance of the histaminergic neuron population are likely an artifact of it being a relatively under-represented cluster even in wild-type mice.
“It is likely that the observed changes in cell abundance are an artifact of it being a relatively under-represented cluster even in the wild-type mice.”
Quote in the paperNot a substantial claim - Interpretationown data
If changes in whole-body energy expenditure were present in CreSynI Idolf/f mice, they were too subtle for the calorimeter to detect.
“however if changes in whole-body energy expenditure were present they were too subtle for the calorimeter to detect.”
Quote in the paperNot a substantial claim - Interpretationown data
The neuronal IDOL-VLDLR pathway has a role in metabolic homeostasis and diet-induced obesity.
“These studies identify a role for the neuronal IDOL-VLDLR pathway in metabolic homeostasis and diet-induced obesity.”
Quote in the paperSubstantial claim - Interpretationown data
Two independent lines of global IDOL-KO mice exhibited a highly reproducible phenotype of resistance to diet-induced obesity.
“Two independent lines of global IDOL-KO mice (one derived at UCLA and one at AstraZeneca) exhibited a highly reproducible phenotype of resistance to diet-induced obesity.”
Quote in the paperSubstantial claim - Interpretationreasoning
The appropriate balance of VLDLR protein levels in the CNS is important for the maintenance of whole-body energy homeostasis.
“Coupled with prior work, our results suggest that the appropriate balance of VLDLR protein levels in the CNS is important for the maintenance of whole-body energy homeostasis.”
Quote in the paperSubstantial claim - Interpretationown data
Regulation of VLDLR protein levels is important for the maintenance of metabolic homeostasis.
“Collectively, these data provide strong evidence for the hypothesis that regulation of VLDLR protein levels is important for the maintenance of metabolic homeostasis.”
Quote in the paperSubstantial claim - Interpretationown data
The liver is not the primary driver of the global IDOL-KO phenotype.
“LDLR is the only IDOL target expressed in the liver, further supporting the conclusion that the liver is not the primary driver of the global IDOL-KO phenotype.”
Quote in the paperSubstantial claim- Rests on an assumption: LDLR is the only IDOL target expressed in the liver.
- Interpretationown data
Adipose-intrinsic actions of IDOL cannot explain the phenotype of global IDOL-knockout mice.
“Collectively the data collected from both gain- and loss-of-function mice lead us to conclude that adipose-intrinsic actions of IDOL cannot explain the phenotype of global IDOL-knockout mice.”
Quote in the paperSubstantial claim - Interpretationown data
The protection against diet-induced obesity and metabolic dysfunction in IDOL-deficient mice is mediated by altered food intake and thermogenesis.
“Here we show that loss of IDOL in mice protects against the development of diet-induced obesity and metabolic dysfunction by altering food intake and thermogenesis.”
Quote in the paperSubstantial claim - Interpretationown data
Activation of HSL indicates that deletion of IDOL from neurons affected peripheral energy homeostasis.
“The activation of HSL clearly indicates that deletion of IDOL from neurons affected peripheral energy homeostasis”
Quote in the paperSubstantial claim - Interpretationown data
Altered abundance of the VLDLR receptor and not the LDLR is an important contributor to systemic energy balance.
“These data strongly suggest that altered abundance of the VLDLR receptor and not the LDLR is an important contributor to systemic energy balance.”
Quote in the paperSubstantial claim - Interpretationown data
Changes in food intake were sufficient to affect body weight in the absence of energy expenditure differences.
“suggesting that changes in food intake were sufficient to affect body weight in the absence of energy expenditure differences”
Quote in the paperSubstantial claim - Interpretationown data
VLDLR rather than LDLR is the primary mediator of IDOL effects on energy balance.
“Finally, we identify VLDLR rather than LDLR as the primary mediator of IDOL effects on energy balance.”
Quote in the paperSubstantial claim - Interpretationown data
Acute knockdown of Idol in the central nervous system is linked to systemic changes in energy expenditure.
“These observations linked acute knockdown of Idol in the central nervous system to systemic changes in energy expenditure”
Quote in the paperSubstantial claim - Interpretationown data
Tissue-specific studies pointed to the CNS as the primary site of IDOL action in the regulation of energy balance.
“Despite the abundant expression of IDOL and its targets in adipose tissue, tissue-specific studies pointed to the CNS as the primary site of IDOL action in the regulation of energy balance.”
Quote in the paperSubstantial claim - Interpretationown data
VLDLR expression is required for the effects of IDOL on whole body metabolism.
“our finding that VLDLR expression is required for the effects of IDOL on whole body metabolism is consistent with prior work demonstrating that VLDLR is important to metabolic homeostasis.”
Quote in the paperSubstantial claim - Interpretationown data
IDOL regulates systemic energy balance through the VLDL receptor.
“IDOL regulates systemic energy balance through the VLDL receptor.”
Quote in the paperSubstantial claim - Interpretationown data
Complete loss of IDOL from neurons provided evidence that IDOL regulates food intake.
“The complete loss of IDOL from neurons provided evidence that IDOL regulates food intake, consistent with the reduced expression of Agrp and Npy seen in our single cell RNA-sequencing data of whole-body IDOL knockout mice.”
Quote in the paperSubstantial claim - Interpretationown data
The IDOL-VLDLR pathway is a previously unrecognized mode of regulating whole-body energy homeostasis.
“Collectively, our studies identify the IDOL-VLDLR pathway as a previously unrecognized mode of regulating whole-body energy homeostasis.”
Quote in the paperSubstantial claim - Study design and conductown data
The marker panel used was sufficient to define all major cell types as well as neuronal subpopulations in the hypothalamus.
“These markers were sufficient to define all major cell types as well as neuronal subpopulations.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 25
- May combine two claims. 16
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationApoE and ApoJ are known ligands for VLDLR.
“Both ApoE and ApoJ (also called Clusterin)–two apolipoproteins found in cerebrospinal fluid–are known ligands for VLDLR26,53,54.”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [26] Andersen, O. M. et al. Essential role of the apolipoprotein E receptor-2 in sperm development. J. Biol. Chem. 278, 23989–23995 (2003). source
- cites [53] Leeb, C., Eresheim, C. & Nimpf, J. Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway. J. Biol. Chem. 289, 4161–4172 (2014). source
The Discussion (page unavailable) states that clusterin binds VLDLR, supporting the ApoJ portion of the claim. The passage comparing VLDLR with the LDL receptor names ApoE as a ligand of the LDL receptor, not VLDLR; no retrieved passage establishes ApoE as a VLDLR ligand. The retrieved passages also do not establish that both proteins are found in cerebrospinal fluid. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [54] Pohlkamp, T., Wasser, C. R. & Herz, J. Functional roles of the interaction of APP and lipoprotein receptors. Front Mol. Neurosci. 10, 54 (2017). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSeveral non-apolipoprotein ligands have been proposed for VLDLR, including Reelin and F-spondin.
“Several non-apolipoprotein ligands have also been proposed for VLDLR, including Reelin2 and F-spondin55.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [2] Trommsdorff, M. et al. Reeler/disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689–701 (1999). source
- cites [55] Zisman, S. et al. Proteolysis and membrane capture of F-spondin generates combinatorial guidance cues from a single molecule. J. Cell Biol. 178, 1237–1249 (2007). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn the periphery, VLDLR has a clear role facilitating lipolytic activity of LPL.
“In the periphery, VLDLR has a clear role facilitating lipolytic activity of LPL20,22”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [20] Yagyu, H. et al. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277, 10037–10043 (2002). source
- cites [22] Goudriaan, J. R. et al. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45, 1475–1481 (2004). source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataEnergy expenditure data from indirect calorimetry were analyzed using two methods: NIDDK MMPC regression and CalR analysis of covariance.
“The energy expenditure data generated by the indirect calorimetry experiment were analyzed using two methods: 1. the NIDDK Mouse Metabolic Phenotyping Centers using their energy expenditure analysis page (http://www.mmpc.org/shared/regression.aspx) and 2. the R programming language with CalR, a custom package for analysis of indirect calorimetry using analysis of covariance with a graphical user”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [31] Mina, A. I. et al. CalR: a web-based analysis tool for indirect calorimetry experiments. Cell Metab. 28, 656–666 (2018). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFree fatty acid sensing by the hypothalamus is a well-established modulator of neuronal activity, affecting peripheral metabolism.
“Free fatty acid sensing by the hypothalamus is a well-established modulator of neuronal activity57, affecting peripheral metabolism58–60”
Quote in the paperNot a substantial claim1 of 4 sources checked- cites [57] Oomura, Y., Nakamura, T., Sugimori, M. & Yamada, Y. Effect of free fatty acid on the rat lateral hypothalamic neurons. Physiol. Behav. 14, 483–486 (1975). source
- cites [58] Lam, T. K. T. et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 11, 320–327 (2005). source
- cites [59] Lam, T. K. T., Schwartz, G. J. & Rossetti, L. Hypothalamic sensing of fatty acids. Nat. Neurosci. 8, 579–584 (2005). source
- cites [60] Yue, J. T. Y. et al. A fatty acid-dependent hypothalamic-DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteins. Nat. Commun. 6, 5970 (2015). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrior studies showed that the IDOL pathway in the CNS affects the function of both microglia and neurons.
“Prior studies showed that the IDOL pathway in the CNS affects the function of both microglia and neurons29,30”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [29] Choi, J. et al. The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis. Sci. Transl. Med. 7, 314ra184 (2015). source
The Results section, “Loss of Idol facilitates ApoE and Aβ uptake and clearance” (page unavailable), shows that Idol regulates Aβ uptake in primary microglia and that Idol knockdown increases uptake in a neuronal cell line. It also reports no change in Aβ uptake in primary mouse neurons lacking Idol, so the broad claim about neuronal function needs that qualification. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [30] Gao, J. et al. The E3 ubiquitin ligase IDOL regulates synaptic ApoER2 levels and is important for plasticity and learning. eLife 6, 1741 (2017). source
The Discussion reports that loss of IDOL impairs neuronal spine remodeling and the plasticity of neural circuits in vivo, supporting the neuronal part of the claim. The passages from our copy do not report an effect of the IDOL pathway on microglial function; a search for “microglia” found no such evidence. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrior mechanistic analyses suggested that VLDLR in the periphery acts in the endothelium to enhance lipoprotein lipase-dependent hydrolysis of triglycerides.
“Prior mechanistic analyses have suggested that VLDLR in the periphery acts in the endothelium to enhance lipoprotein lipase-dependent hydrolysis of triglycerides20–23.”
Quote in the paperNot a substantial claim2 of 4 sources checked- cites [20] Yagyu, H. et al. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277, 10037–10043 (2002). source
- cites [21] Garcia-Arcos, I. et al. Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology. J. Biol. Chem. 288, 14046–14058 (2013). source
- cites [22] Goudriaan, J. R. et al. The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis. J. Lipid Res. 45, 1475–1481 (2004). source
- cites [23] Obunike, J. C. et al. Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor. J. Biol. Chem. 276, 8934–8941 (2001). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAGRP neurons have been associated with the negative regulation of energy expenditure.
“AGRP neurons have also been associated with the negative regulation of energy expenditure36–38.”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [36] Caron, A., Lee, S., Elmquist, J. K. & Gautron, L. Leptin and brain-adipose crosstalks. Nat. Rev. Neurosci. 19, 153–165 (2018). source
- cites [37] Kong, D. et al. GABAergic RIP-Cre neurons in the arcuate nucleus selectively regulate energy expenditure. Cell 151, 645–657 (2012). source
- cites [38] Ruan, H.-B. et al. O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat. Cell 159, 306–317 (2014). source
May combine two claims.
Findingown dataIDOL-KO mice on western diet had reduced hepatic lipid accumulation and smaller adipocytes in the inguinal white adipose tissue depot.
“This was accompanied by reduced hepatic lipid accumulation and smaller adipocytes in the inguinal white adipose tissue depot”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere were no differences in lean body mass, nasal to anal length, or body temperature attributable to genotype in IDOL-knockout mice.
“There were no differences in lean body mass (Extended Data Fig. 1F), nasal to anal length (Extended Data Fig. 1G), or to body temperature attributable to genotype (Extended Data Fig. 1H).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIDOL-KO and IDOL-LDLR DKO groups had improved glucose clearance and enhanced response to insulin relative to WT, while the IDOL-VLDLR DKO group was indistinguishable from WT.
“Both the IDOL-KO and IDOL-LDLR DKO groups had improved glucose clearance and enhanced response to a bolus of insulin relative to the WT group; however, the IDOL-VLDLR DKO group was indistinguishable from the WT group.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataClustering analysis combined with expression profiling of a panel of marker genes discriminated 26 unique clusters of cells in the hypothalamus.
“Clustering analysis combined with expression profiling of a panel of marker genes allowed us to discriminate 26 unique clusters of cells in the hypothalamus.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataaP2-IDOL transgenic mice fed WD for twelve weeks showed no differences in mass, adiposity, or glucose and insulin responses compared to littermate controls.
“we observed no differences in mass between the aP2-IDOL Tg mice and their littermate controls fed WD for twelve weeks (Extended Data Fig. 3C). Accordingly, neither adiposity nor responses to glucose and insulin challenges were affected by the transgene (Extended Data Fig. 3D–3F).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIdol-knockdown mice had smaller white adipose tissue depots containing smaller adipocytes, but no obvious increase in multi-locular cells resembling beige adipocytes.
“The Idol-knockdown mice also had smaller white adipose tissue depots containing smaller adipocytes, but we did not find an obvious increase in multi-locular cells resembling beige adipocytes”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataASO-treated mice appeared to have increased carbohydrate metabolism, but no consistent change in fat oxidation was observed.
“The ASO-treated mice appeared to have increased carbohydrate metabolism, but we did not observe a consistent change in fat oxidation”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataHistological analysis of brown adipose tissue in ASO-treated mice revealed smaller cells with more abundant lipid droplets.
“Histological analysis of brown adipose tissue revealed smaller cells with more abundant lipid droplets (Fig. 4E), consistent with increased energy expenditure.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIdol ASO-treated mice were leaner by MRI analysis and had smaller fat pads upon dissection.
“Consistent with the whole-body knockout, the Idol ASO-treated mice were leaner by MRI analysis (Fig. 4D) and had smaller fat pads upon dissection”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDeletion of IDOL has a more pronounced protective effect on WT mice but no additional effect on the background of VLDLR deficiency.
“has an even more pronounced protective effect on WT mice, but has no additional effect on the background of VLDLR deficiency.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe ARC image shows GFP-positive cells demonstrating successful infection of neurons and is representative of the sixteen mice injected in the ARC study.
“An image of the ARC showing GFP-positive cells to demonstrate successful infection of neurons; the image is representative of the sixteen mice injected in the ARC study.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataDeletion of IDOL from neurons protected mice against diet-induced obesity by reducing food intake while enhancing energy expenditure pathways.
“our work with the SynI-Cre mice clearly demonstrated that deletion of IDOL from neurons protected mice against diet-induced obesity by reducing food intake while enhancing energy expenditure pathways.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenWestern blots shown are representative of many independent experiments conducted by two independent researchers.
“This blot is representative of many independent experiments conducted by two independent researchers.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe western blot image is representative of many independent experiments.
“The image is representative of many independent experiments.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe acute nature of the ASO studies allowed detection of increased energy expenditure at a whole-organism level, linking IDOL in the CNS to peripheral energy homeostasis.
“The acute nature of the ASO studies allowed us to detect increased energy expenditure at a whole-organism level, linking IDOL in the CNS to peripheral energy homeostasis.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is evidence that ApoJ can bind and modulate Leptin response in cell culture.
“While there is evidence that ApoJ can bind and modulate Leptin response in cell culture56”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Bajari, T. M., Strasser, V., Nimpf, J. & Schneider, W. J. A model for modulation of leptin activity by association with clusterin. FASEB J. 17, 1505–1507 (2003). source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe phenotype of the UCLA global IDOL KO mice is consistent between different vivarium conditions.
“Nevertheless, we conclude that the phenotype of the UCLA global IDOL KO mice is consistent between different vivarium conditions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenIDOL forms a homodimer which recognizes a specific conserved amino acid sequence in its membrane-bound targets for recognition and ubiquitin transfer, and only three proteins have been identified that meet this criterion: LDLR, VLDLR, and ApoER2.
“IDOL forms a homodimer which recognizes a specific conserved amino acid sequence in its membrane-bound targets for recognition and ubiquitin transfer. To date only three proteins have been identified that meet this stringent criterion: the LDL receptor and its two most closely-related family members, VLDL receptor and ApoER2.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenDouble knockout cohorts were arranged to maximize the number of littermate controls.
“Each cohort in the double knockout studies was arranged to maximize the number of littermate controls.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe macroscopic images of adipose depots are representative of the ten mice per group in the ASO study.
“These images are representative of the ten mice per group in the ASO study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationActing via the sympathetic nervous system, the hypothalamus is a key effector of CNS influence on adipose tissue, including response to cold.
“Acting via the sympathetic nervous system32,43,44. the hypothalamus is a key effector of CNS influence on adipose tissue, including response to cold.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [32] Cannon, B. & Nedergaard, J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277–359 (2004). source
- cites [43] Chechi, K., Carpentier, A. C. & Richard, D. Understanding the brown adipocyte as a contributor to energy homeostasis. Trends Endocrinol. Metab. 24, 408–420 (2013). source
- cites [44] Bamshad, M., Song, C. K. & Bartness, T. J. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am. J. Physiol. 276, R1569–R1578 (1999). source
Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Study design and conductreasoningAll studies were performed with male mice.
“All studies performed with male mice in climate-controlled facilities maintained on a 12h light/dark cycle constant temperature of 22°C with group housed mice, unless otherwise noted.”
Quote in the paperNot a substantial claim- Rests on an assumption: Female mice are resistant to diet-induced obesity and required prolonged challenges with more severe diets to elicit adiposity changes.
May combine two claims.
Interpretationown dataIncreased VLDLR protein levels in the hypothalamus of both IDOL-KO and IDOL-ASO-treated mice suggest that this region likely contributes to IDOL's metabolic effects.
“We observed increased VLDLR protein levels in hypothalamus of both the IDOL-KO mice and IDOL-ASO-treated mice, suggesting that this region likely contributes to IDOL’s metabolic effects.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIndividual populations of neurons within a given hypothalamic nucleus may have opposing effects, as with POMC and AGRP neurons in the arcuate nucleus.
“Individual populations of neurons within a given hypothalamic nucleus may have opposing effects, as with POMC and AGRP neurons in the arcuate nucleus52.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J. & Baskin, D. G. Central nervous system control of food intake. Nature 404, 661–671 (2000). source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe liver histology images are representative of three mice per treatment group analyzed for histology.
“These images are representative of three mice per treatment group that were analyzed for histology.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe western blot samples were repeated twice to assess reproducibility.
“These samples were repeated twice to assess reproducibility.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll data except energy expenditure data were analyzed using GraphPad Prism v7 with a predetermined alpha value of 0.05.
“All data except the Energy Expenditure data were analyzed using GraphPad Prism v7 with a predetermined alpha value of 0.05.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenMouse studies conducted at UCLA were reviewed and approved by the Chancellor's Animal Research Committee, and mouse studies conducted by AstraZeneca were approved by the Gothenburg Ethics Committee for Experimental Animals.
“The mouse studies conducted at UCLA were reviewed and approved by the Chancellor’s Animal Research Committee. The mouse studied conducted by AstraZeneca were approved by Gothenburg Ethics Committee for Experimental Animals, license nr: 38–2011.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe PVH image shows GFP-positive cells demonstrating successful infection of neurons and is representative of the seventeen mice injected in the PVH experiment.
“An image of the PVH showing GFP-positive cells to demonstrate successful infection of neurons; the image is representative of the seventeen mice injected in the PVH experiment.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
IDOL and its targets are expressed in a number of metabolically-active tissues other than liver.
“IDOL and its targets are expressed in a number of metabolically-active tissues other than liver, but the physiological role of IDOL in systemic lipid metabolism remains poorly understood.”
The paper relies on this without support.
The physiological role of IDOL in systemic lipid metabolism remains poorly understood.
“IDOL and its targets are expressed in a number of metabolically-active tissues other than liver, but the physiological role of IDOL in systemic lipid metabolism remains poorly understood.”
The paper relies on this without support.
The lipoprotein receptor(s) through which IDOL regulates metabolism are unknown.
“Furthermore, the lipoprotein receptor(s) through which IDOL regulates metabolism are unknown.”
The paper relies on this without support.
VLDLR is most highly expressed in the brain, muscle, fat, and the endothelium.
“VLDLR is most highly expressed in the brain, muscle, fat, and the endothelium.”
The paper relies on this without support.
The possibility that central actions of IDOL affect metabolism has not been addressed.
“however, the possibility that central actions of IDOL affect metabolism has not been addressed.”
The paper relies on this without support.
Female mice are resistant to diet-induced obesity and required prolonged challenges with more severe diets to elicit adiposity changes.
“Pilot studies used both genders of mice; however, female mice are resistant to diet-induced obesity and required prolonged challenges with more severe diets to elicit adiposity changes.”
The paper relies on this without support.
LDLR is the only IDOL target expressed in the liver.
“LDLR is the only IDOL target expressed in the liver, further supporting the conclusion that the liver is not the primary driver of the global IDOL-KO phenotype.”
The paper relies on this without support.
Infection of neurons with AAV-hSyn-GFP-Cre in the arcuate nucleus or paraventricular nucleus of the hypothalamus successfully deletes IDOL in those neurons.
“An image of the ARC showing GFP-positive cells to demonstrate successful infection of neurons”
“An image of the PVH showing GFP-positive cells to demonstrate successful infection of neurons”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IDOL plays a critical role in the regulation of neuronal VLDLR expression and systemic energy balance.
“In addition, IDOL plays a critical role in the regulation of neuronal VLDLR expression and systemic energy balance (Lee et al 2019).”
From ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease (2022) · cites this paper as Lee et al 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
ASO dose-response measurement time differs
MinorThe Results say whole-brain samples for the dose-response study were collected two weeks after injection, while the Extended Data caption says Idol expression was measured eight weeks after injection.
“Dose-response studies determined that 40 μg given by intracerebroventricular injection was the minimum dose required for maximal suppression of Idol expression in whole brain homogenates collected two weeks after the injection”
“Optimization of the dose of ASO required to suppress Idol expression in whole-brain homogenates measured 8-weeks post-injection.”
Cites
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110 · see citing works
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451 · see citing works
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433 · see citing works
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487 · see citing works
Protein Sensors for Membrane Sterols
Goldstein, J. L., DeBose‐Boyd, R. A., & Brown, M. S. (2006) · Cell · doi:10.1016/j.cell.2005.12.022 · Cited by 1,677 · see citing works
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302 · see citing works
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261 · see citing works
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science · doi:10.1126/science.1189862 · Cited by 1,260 · see citing works
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Goldstein, J. L., & Brown, M. S. (2015) · Cell · doi:10.1016/j.cell.2015.01.036 · Cited by 1,233 · see citing works
Brüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L. J., & Kahn, C. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80155-0 · Cited by 1,183 · see citing works
A smart local moving algorithm for large-scale modularity-based community detection
Waltman, L., & van Eck, N. J. (2013) · The European Physical Journal B · doi:10.1140/epjb/e2013-40829-0 · Cited by 1,088 · see citing works
LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
Zelcer, N., Hong, C., Boyadjian, R., & Tontonoz, P. (2009) · Science · doi:10.1126/science.1168974 · Cited by 848 · see citing works
Self-citationA molecular census of arcuate hypothalamus and median eminence cell types
Campbell, J. N., Macosko, E. Z., Fenselau, H., Pers, T. H., Lyubetskaya, A., Tenen, D., Goldman, M., Verstegen, A. M. J., Resch, J. M., McCarroll, S. A., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4495 · Cited by 817 · see citing works
A guide to analysis of mouse energy metabolism
Tschöp, M. H., Speakman, J. R., Arch, J. R. S., Auwerx, J., Brüning, J. C., Chan, L., Eckel, R. H., Farese, R. V., Galgani, J. E., Hambly, C., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1806 · Cited by 813 · see citing works
Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
López, M., Varela, L., Vazquez, M. J., Rodríguez‐Cuenca, S., González, C. R., Velagapudi, V., Morgan, D. A., Schoenmakers, E., Agassandian, K., Lage, R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2207 · Cited by 674 · see citing works
Transcriptional Control of Adipose Lipid Handling by IRF4
Eguchi, J., Wang, X., Yu, S., Kershaw, E. E., Chiu, P. C., Dushay, J. R., Estall, J. L., Klein, U., Maratos–Flier, E., & Rosen, E. D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.005 · Cited by 607 · see citing works
Single-Cell RNA-Seq Reveals Hypothalamic Cell Diversity
Chen, R., Wu, X., Jiang, L., & Zhang, Y. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.004 · Cited by 592 · see citing works
Liver X receptors in lipid metabolism: opportunities for drug discovery
Hong, C., & Tontonoz, P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4280 · Cited by 587 · see citing works
Self-citationFGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss
Owen, B. M., Ding, X., Morgan, D. A., Coate, K. C., Bookout, A. L., Rahmouni, K., Kliewer, S. A., & Mangelsdorf, D. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.012 · Cited by 523 · see citing works
Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes
Romanov, R. A., Zeisel, A., Bakker, J., Girach, F., Hellysaz, A., Tomer, R., Alpár, A., Mulder, J., Clotman, F., Keimpema, E., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4462 · Cited by 502 · see citing works
Hypothalamic sensing of fatty acids
Lam, T. K. T., Schwartz, G. J., & Rossetti, L. (2005) · Nature Neuroscience · doi:10.1038/nn1456 · Cited by 478 · see citing works
Swayze, E. E., Siwkowski, A. M., Wancewicz, E. V., Migawa, M. T., Wyrzykiewicz, T. K., Hung, G., Monia, B. P., & Bennett, A. C. F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1071 · Cited by 473 · see citing works
CalR: A Web-Based Analysis Tool for Indirect Calorimetry Experiments
Mina, A. I., LeClair, R. A., LeClair, K. B., Cohen, D. E., Lantier, L., & Banks, A. S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.019 · Cited by 458 · see citing works
Alva, J. A., Zovein, A. C., Monvoisin, A., Murphy, T. J., Salazar, A., Harvey, N. L., Carmeliet, P., & Iruela‐Arispe, M. L. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20643 · Cited by 455 · see citing works
Isolation and culture of adult neurons and neurospheres
Brewer, G. J., & Torricelli, J. R. (2007) · Nature Protocols · doi:10.1038/nprot.2007.207 · Cited by 448 · see citing works
Neuronal Regulation of Energy Homeostasis: Beyond the Hypothalamus and Feeding
Waterson, M. J., & Horváth, T. L. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.026 · Cited by 439 · see citing works
CNS origins of the sympathetic nervous system outflow to brown adipose tissue
Bamshad, M., Song, C. K., & Bartness, T. J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.6.r1569 · Cited by 437 · see citing works
Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis
Lam, T. K. T., Pocai, A., Gutierrez-Juarez, R., Obici, S., Bryan, J., Aguilar-Bryan, L., Schwartz, G. J., & Rossetti, L. (2005) · Nature Medicine · doi:10.1038/nm1201 · Cited by 432 · see citing works
Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
Berbée, J. F. P., Boon, M. R., Khedoe, P. P. S. J., Bartelt, A., Schlein, C., Worthmann, A., Kooijman, S., Hoeke, G., Mol, I. M., John, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7356 · Cited by 428 · see citing works
From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior
Williams, K. W., & Elmquist, J. K. (2012) · Nature Neuroscience · doi:10.1038/nn.3217 · Cited by 421 · see citing works
Leptin and brain–adipose crosstalks
Caron, A., Lee, S., Elmquist, J. K., & Gautron, L. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.7 · Cited by 284 · see citing works
Self-citationO-GlcNAc Transferase Enables AgRP Neurons to Suppress Browning of White Fat
Ruan, H.-B., Dietrich, M. O., Liu, Z.-W., Zimmer, M. R., Li, M.-D., Singh, J. P., Zhang, K., Yin, R., Wu, J., Horvath, T. L., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.010 · Cited by 281 · see citing works
Self-citationFrykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L., & Herz, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8453 · Cited by 256 · see citing works
20 YEARS OF LEPTIN: Leptin at 20: an overview
Friedman, J. M. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0405 · Cited by 249 · see citing works
Statistical significance of variables driving systematic variation in high-dimensional data
Chung, N. C., & Storey, J. D. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu674 · Cited by 247 · see citing works
Neural Control of Energy Balance: Translating Circuits to Therapies
Gautron, L., Elmquist, J. K., & Williams, K. W. (2015) · Cell · doi:10.1016/j.cell.2015.02.023 · Cited by 240 · see citing works
Lu, M. M., Sarruf, D. A., Talukdar, S., Sharma, S., Li, P., Bandyopadhyay, G. K., Nalbandian, S., Fan, W., Gayen, J. R., Mahata, S. K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2332 · Cited by 227 · see citing works
Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis
Sallam, T., Jones, M. C., Gilliland, T., Zhang, L., Wu, X., Eskin, A., Sandhu, J., Casero, D., Vallim, T. Q. D. A., Hong, C., et al. (2016) · Nature · doi:10.1038/nature17674 · Cited by 217 · see citing works
Self-citationGABAergic RIP-Cre Neurons in the Arcuate Nucleus Selectively Regulate Energy Expenditure
Kong, D., Tong, Q., Ye, C., Koda, S., Fuller, P. M., Krashes, M. J., Vong, L., Ray, R. S., Olson, D. P., & Lowell, B. B. (2012) · Cell · doi:10.1016/j.cell.2012.09.020 · Cited by 215 · see citing works
Seth, P. P., Vasquez, G., Allerson, C. A., Berdeja, A., Gaus, H. J., Kinberger, G. A., Prakash, T. P., Migawa, M. T., Bhat, B., & Swayze, E. E. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo902560f · Cited by 211 · see citing works
Identification of a Brainstem Circuit Controlling Feeding
Nectow, A. R., Schneeberger, M., Zhang, H., Field, B. C., Renier, N., Azevedo, E. P., Patel, B., Liang, Y., Mitra, S. S., Tessier‐Lavigne, M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.045 · Cited by 166 · see citing works
Østergaard, M. E., Southwell, A. L., Kordasiewicz, H. B., Watt, A. T., Skotte, N. H., Doty, C. N., Vaid, K., Villanueva, E. B., Swayze, E. E., Bennett, C. F., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt725 · Cited by 163 · see citing works
Effect of free fatty acid on the rat lateral hypothalamic neurons
Oomura, Y., Nakamura, T., Sugimori, M., & Yamada, Y. (1975) · Physiology & Behavior · doi:10.1016/0031-9384(75)90015-3 · Cited by 144 · see citing works
Hong, C., Duit, S., Jalonen, P., Out, R., Scheer, L., Sorrentino, V., Boyadjian, R., Rodenburg, K. W., Foley, E., Korhonen, L., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123729 · Cited by 142 · see citing works
Self-citationLiver X receptors at the intersection of lipid metabolism and atherogenesis
Lee, S. D., & Tontonoz, P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.042 · Cited by 133 · see citing works
Self-citationProtection From Obesity in Mice Lacking the VLDL Receptor
Goudriaan, J. R., Tacken, P. J., Dahlmans, V. E. H., Gijbels, M. J. J., van Dijk, K. W., Havekes, L. M., & Jong, M. C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095147 · Cited by 133 · see citing works
Very Low Density Lipoprotein (VLDL) Receptor-deficient Mice Have Reduced Lipoprotein Lipase Activity
Yagyu, H., Lutz, E. P., Kako, Y., Marks, S., Hu, Y., Choi, S. Y., Bensadoun, A., & Goldberg, I. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109966200 · Cited by 123 · see citing works
Essential role of UCP1 modulating the central effects of thyroid hormones on energy balance
Álvarez-Crespo, M., Csikasz, R. I., Martínez‐Sánchez, N., Diéguez, C., Cannon, B., Nedergaard, J., & López, M. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.008 · Cited by 118 · see citing works
Essential Role of the Apolipoprotein E Receptor-2 in Sperm Development
Andersen, O. M., Yeung, C.-H., Vorum, H., Wellner, M., Andreassen, T. K., Erdmann, B., Mueller, E.-C., Herz, J., Otto, A., Cooper, T. G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302157200 · Cited by 112 · see citing works
Goudriaan, J. R., Santo, S. M. S. E., Voshol, P. J., Teusink, B., van Dijk, K. W., van Vlijmen, B. J. M., Romijn, J. A., Havekes, L. M., & Rensen, P. C. N. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400009-jlr200 · Cited by 100 · see citing works
Leeb, C., Eresheim, C., & Nimpf, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529271 · Cited by 99 · see citing works
Understanding the brown adipocyte as a contributor to energy homeostasis
Chechi, K., Carpentier, A. C., & Richard, D. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.04.002 · Cited by 99 · see citing works
Functional Roles of the Interaction of APP and Lipoprotein Receptors
Pohlkamp, T., Wasser, C. R., & Herz, J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00054 · Cited by 92 · see citing works
Obunike, J. C., Lutz, E. P., Li, Z., Paka, L., Katopodis, T., Strickland, D. K., Kozarsky, K. F., Pillarisetti, S., & Goldberg, I. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008813200 · Cited by 91 · see citing works
The LXR–Idol Axis Differentially Regulates Plasma LDL Levels in Primates and Mice
Hong, C., Marshall, S. M., McDaniel, A. L., Graham, M., Layne, J. D., Cai, L., Scotti, E., Boyadjian, R., Kim, J., Chamberlain, B. T., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.001 · Cited by 87 · see citing works
Self-citationThe IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor
Zhang, L., Fairall, L., Goult, B. T., Calkin, A. C., Hong, C., Millard, C. J., Tontonoz, P., & Schwabe, J. W. R. (2011) · Genes & Development · doi:10.1101/gad.2056211 · Cited by 86 · see citing works
Self-citationScotti, E., Calamai, M., Goulbourne, C. N., Zhang, L., Hong, C., Lin, R. R., Choi, J., Pilch, P. F., Fong, L. G., Zou, P., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01716-12 · Cited by 80 · see citing works
Self-citationScotti, E., Hong, C., Yoshinaga, Y., Tu, Y., Hu, Y., Zelcer, N., Boyadjian, R., de Jong, P. J., Young, S. G., Fong, L. G., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01469-10 · Cited by 77 · see citing works
Self-citationWeissglas-Volkov, D., Calkin, A. C., Tusie-Luna, T., Sinsheimer, J. S., Zelcer, N., Riba, L., Tino, A. M. V., Ordoñez-Sánchez, M. L., Cruz-Bautista, I., Aguilar-Salinas, C. A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45504 · Cited by 66 · see citing works
Self-citationBoth K63 and K48 ubiquitin linkages signal lysosomal degradation of the LDL receptor
Zhang, L., Xu, M., Scotti, E., Chen, Z. J., & Tontonoz, P. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m035774 · Cited by 64 · see citing works
Self-citationCalkin, A. C., Goult, B. T., Zhang, L., Fairall, L., Hong, C., Schwabe, J. W. R., & Tontonoz, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111589108 · Cited by 62 · see citing works
Self-citationAdipose-specific Lipoprotein Lipase Deficiency More Profoundly Affects Brown than White Fat Biology
Garcia-Arcos, I., Hiyama, Y., Drosatos, K., Bharadwaj, K. G., Hu, Y., Son, N. H., O'Byrne, S. M., Chang, C. L., Deckelbaum, R. J., Takahashi, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.469270 · Cited by 59 · see citing works
Sorrentino, V., Fouchier, S. W., Motazacker, M. M., Nelson, J. K., Defesche, J. C., Dallinga‐Thie, G. M., Kastelein, J. J. P., Hovingh, G. K., & Zelcer, N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs472 · Cited by 58 · see citing works
Zisman, S., Marom, K., Avraham, O., Rinsky-Halivni, L., Gai, U., Kligun, G., Tzarfaty-Majar, V., Suzuki, T., & Klar, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702184 · Cited by 50 · see citing works
Choi, J., Gao, J., Kim, J., Hong, C., Kim, J., & Tontonoz, P. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad1904 · Cited by 49 · see citing works
Self-citationYue, J. T. Y., Abraham, M. A., LaPierre, M. P., Mighiu, P. I., Light, P. E., Filippi, B. M., & Lam, T. K. T. (2015) · Nature Communications · doi:10.1038/ncomms6970 · Cited by 46 · see citing works
A model for modulation of leptin activity by association with clusterin
Bajari, T. M., Strasser, V., Nimpf, J., & Schneider, W. J. (2003) · The FASEB Journal · doi:10.1096/fj.02-1106fje · Cited by 45 · see citing works
CalR: A Web-based Analysis Tool for Indirect Calorimetry ExperimentsPreprint
Mina, A. I., LeClair, R. A., LeClair, K. B., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/213967 · Cited by 35 · see citing works
Gao, J., Marosi, M., Choi, J., Achiro, J. M., Kim, S., Li, S., Otis, K., Martin, K. C., Portera-Cailliau, C., & Tontonoz, P. (2017) · eLife · doi:10.7554/elife.29178 · Cited by 30 · see citing works
Self-citationDevelopmental changes in embryonic hypothalamic neurons during prenatal fat exposure
Poon, K., Barson, J. R., Fagan, S. E., & LEIBOWITZ, S. F. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00238.2012 · Cited by 28 · see citing works
van Loon, N. M., Ottenhoff, R., Kooijman, S., Moeton, M., Scheij, S. S., Abbing, R. L. P. R., Gijbels, M. J., Levels, J. H. M., Sorrentino, V., Berbée, J. F. P., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311168 · Cited by 28 · see citing works
Calkin, A. C., Lee, S. D., Kim, J., van Stijn, C. M. W., Wu, X., Lusis, A. J., Hong, C., Tangirala, R. K., & Tontonoz, P. (2014) · Circulation Research · doi:10.1161/circresaha.115.304440 · Cited by 26 · see citing works
Self-citationBrain nuclear receptors and body weight regulation
Xu, Y., O’Malley, B. W., & Elmquist, J. K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88891 · Cited by 25 · see citing works
Viral Vectors for Studying Brain Mechanisms that Control Energy Homeostasis
Mancini, G., & Horvath, T. L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.015 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
HypoMap—a unified single-cell gene expression atlas of the murine hypothalamus
Steuernagel, L., Lam, B. Y. H., Klemm, P., Dowsett, G. K. C., Bauder, C. A., Tadross, J. A., Hitschfeld, T. S., del Rio Martin, A., Chen, W., de Solis, A. J., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00657-y · Cited by 267 · see citing works
The ubiquitous role of ubiquitination in lipid metabolism
Loix, M., Zelcer, N., Bogie, J. F. J., & Hendriks, J. J. A. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.09.001 · Cited by 64 · see citing works
ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
Li, Y., Macyczko, J. R., Liu, C.-C., & Bu, G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.011 · Cited by 61 · see citing works
Herb, B. R., Glover, H. J., Bhaduri, A., Colantuoni, C., Bale, T. L., Siletti, K., Linnarsson, S., Hodge, R. D., Lein, E. S., Kriegstein, A. R., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf6251 · Cited by 55 · see citing works
25-Hydroxycholesterol as a Signaling Molecule of the Nervous System
Odnoshivkina, Y. G., Kuznetsova, E. A., & Petrov, A. M. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922060049 · Cited by 47 · see citing works
Dreher, S. I., Irmler, M., Pivovarova‐Ramich, O., Kessler, K., Jürchott, K., Sticht, C., Fritsche, L., Schneeweiß, P., Machann, J., Pfeiffer, A. F. H., et al. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01271-y · Cited by 43 · see citing works
microRNA-33 controls hunger signaling in hypothalamic AgRP neurons
Price, N. L., Fernández-Tussy, P., Varela, L., Cardelo, M. P., Shanabrough, M., Aryal, B., de Cabo, R., Suárez, Y., Horvath, T. L., & Fernández-Hernando, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46427-0 · Cited by 25 · see citing works
“Tissue digestion was performed as previously described 50,51 .”
MethodSUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1
Wang, J.-Q., Lin, Z., Li, L., Zhang, S.-Y., Li, W., Liu, W., Song, B.-L., & Luo, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015420 · Cited by 22 · see citing works
Regulation of intestinal LDLR by the LXR-IDOL axis
van Loon, N. M., van Wouw, S. A. E., Ottenhoff, R., Nelson, J. K., Kingma, J., Scheij, S. S., Moeton, M., & Zelcer, N. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.10.898 · Cited by 19 · see citing works
Raptin, a sleep-induced hypothalamic hormone, suppresses appetite and obesity
Xie, L., Hu, B., Lu, R.-B., Cheng, Y., Chen, X., Wen, J., Xiao, Y., An, Y.-Z., Peng, N., Dai, Y., et al. (2025) · Cell Research · doi:10.1038/s41422-025-01078-8 · Cited by 18 · see citing works
The low-density lipoprotein receptor: Emerging post-transcriptional regulatory mechanisms
Ndoj, K., Meurs, A., Papaioannou, D., Bjune, K., & Zelcer, N. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119082 · Cited by 16 · see citing works
Yu, Q., Zheng, H., & Zhang, Y. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106878 · Cited by 16 · see citing works
Ren, Z., Zhou, J., Yang, D., Guo, Y., Zhang, J., Xu, J., & Chen, Y. E. (2026) · Cells · doi:10.3390/cells15020134 · Cited by 13 · see citing works
Erythropoietin regulates energy metabolism through EPO-EpoR-RUNX1 axis
Yin, W., Rajvanshi, P. K., Rogers, H. M., Yoshida, T., Kopp, J. B., An, X., Gassmann, M., & Noguchi, C. T. (2024) · Nature Communications · doi:10.1038/s41467-024-52352-z · Cited by 11 · see citing works
Li, J., Li, Z., Li, X., Li, Z., Song, Y., Yuan, L., Wang, Y., Yan, R., Lai, F., Wang, J., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08200-x · Cited by 8 · see citing works
Brap regulates liver morphology and hepatocyte turnover via modulation of the Hippo pathway
Priest, C., Nagari, R. T., Bideyan, L., Lee, S. D., Nguyen, A., Xu, X., & Tontonoz, P. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2201859119 · Cited by 6 · see citing works
Self-citationLi, Z., Li, J., Li, Z., Song, Y., Wang, Y., Wang, C., Yuan, L., Xiao, W., & Wang, J. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012227 · Cited by 4 · see citing works
From identity to function: unveiling the cellular complexity of hypothalamic feeding circuits
Littleton, S. H., Tadross, J. A., & Yeo, G. S. H. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-10004-7 · Cited by 2 · see citing works
CircSlc17a5 controlled by VLDLR/QKI pathway regulated the choroidal angiogenesis
Deng, F., Chen, C.-B., Li, H., Huang, S., Xu, C., & Xiao, X. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119802 · Cited by 2 · see citing works
Liu, Y., Bondarenko, A., Zhang, H., Luan, P., Zhang, Q., Wang, B., Najam, S. S., Liang, X., Syed, A. A. S., Lin, D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.02.601503 · Cited by 1 · see citing works
IDOL alleviates the body weight by upregulating UCP ‐1 in mice
Guan, H., Wang, L., Tang, C., Xu, H., Xiang, A., Chen, X., Yu, Q., & Xu, L. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16127
ApoE Receptors, Molecular Processes, and Cellular Signaling Pathways
Jaeschke, A., & Hui, D. Y. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_6-1
VLDLR: A Multifunctional receptor in diverse pathophysiological processes
Wang, X., Chen, Y., Wei, J., Li, Y., Xu, J., Dai, T., Tang, N., Han, C., & Zhou, Y. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02842-y
Milewski, T. M., Mahach, K. M., Miller-Crews, I., Hofmann, H. A., & Curley, J. P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.30.721920
Yokoyama, K., Chiba, M., Takei, N., Suto, K., Ishio, T., Goto, H., Endo, T., Kadin, M. E., Maeda, M., Watanabe, M., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03970-y
Genetic variation in MYLIP is associated with lipid, thyroid, liver, and hematologic traits in women
Klevjer, M., Nordeidet, A. N., Kararigas, G., & Bye, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-71785-8
- Authors
- Lee, S. D., Priest, C., Bjursell, M., Gao, J., Arneson, D. V., Ahn, I. S., Diamante, G., van Veen, J. E., Massa, M. G., Calkin, A. C., Kim, J., Andersén, H., Rajbhandari, P., Porritt, M., Carreras, A., Ahnmark, A., Seeliger, F., Maxvall, I., Eliasson, P., Althage, M., Åkerblad, P., Lindén, D., Cole, T. A., Lee, R., Boyd, H., Bohlooly-Y, M., Correa, S. M., Yang, X., Tontonoz, P., & Hong, C.
- Affiliations
- University of California, Los Angeles (US)
- AstraZeneca (Sweden) (SE)
- Ionis Pharmaceuticals (United States) (US)
- AstraZeneca (United Kingdom) (GB)
- Corresponding author
- Tontonoz, Peter
- ORCID
- Lee, Stephen D.
- Bjursell, Mikael
- Gao, Jie
- Arneson, Douglas V.
- Diamante, Graciel
- Massa, Megan G.
- Calkin, Anna C.
- Kim, Jason
- Rajbhandari, Prashant
- Porritt, Michelle
- Carreras, Alba
- Ahnmark, Andrea
- Seeliger, Frank
- Maxvall, Ingela
- Althage, Magnus
- Åkerblad, Peter
- Lindén, Daniel
- Lee, Richard
- Boyd, Helen
- Correa, Stephanie M.
- Yang, Xia
- Tontonoz, Peter
- Hong, Cynthia
- Venue
- Nature Metabolism
- Published
- 2019-10-28
- Volume
- 1
- Issue
- 11
- Pages
- 1089-1100
- ISSN
- 2522-5812 (ISSN-L)
- PMC
- PMC7028310
- OpenAlex
- W2981614517
- Cited by
- 26
- References
- 73
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 2
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL136618, DK063491)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- idols, VLDLR, LDL receptor, E3 ubiquitin ligase, energy balance, diet-induced obesity, dietary intake, thermogenesis, hypothalamus, metabolic homeostasis, liver X receptor
- MeSH terms
- Animals, Blood Glucose, Diet, Energy Metabolism, Hypothalamus, Insulin Resistance, Neurons, Obesity, Receptors, LDL, Mice, Knockout, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review